Stan Karbowiak: ‘The Man With the Golden Arm’ Changed the Fate of Millions of Babies
Stan Karbowiak, CEO and Founder – Medical and Wellness Information Specialist at MyHealthCRM, shared a post on LinkedIn:
“James Harrison’s story begins when he was a teenager recovering from major chest surgery in the 1950s, during which he received large amounts of donated blood to survive.
That experience left him determined to ‘give back’ once he was old enough to donate himself.
When he finally did, doctors discovered something extraordinary in his plasma: a rare antibody known as anti‑D, likely formed because of the transfusions he received as a boy.
This antibody turned out to be the key to preventing Rhesus disease, a condition that once caused thousands of newborn deaths each year.
Throughout the next six decades, Harrison donated plasma as often as Australian guidelines allowed, every two weeks, ultimately reaching 1,173 donations before mandatory age limits forced him to stop at 81.
His plasma was used to create ‘RhoGAM‑type injections’, which protect Rh‑negative mothers from developing antibodies that could attack their unborn babies.
Before this treatment existed, many women lost multiple pregnancies; after it became widespread, infant mortality from Rhesus disease plummeted across Australia.
Because his antibodies were so uniquely effective, Harrison became known nationwide as ‘The Man with the Golden Arm,’ and his donations are credited with saving over 2.5 million babies, a number so large that entire generations owe their lives to him.
Despite the fame, he remained humble, treating each donation like a simple errand rather than a heroic act. His legacy continues today through other anti‑D donors and ongoing research into lab‑made monoclonal antibodies that may one day replace the need for rare individuals like him.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy